Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Clinical trial NCT00826280 · COMPLETED
Trial details
- NCT number
- NCT00826280
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-24
- Primary completion
- 2010-07-15
- Enrollment
- 347
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.